Evariant raises Series C funding from McKesson, Salesforce
Farmington, Conn.-based Evariant, a provider of a healthcare-focused CRM platform, announced it has raised additional funding from McKesson Ventures and Salesforce Ventures as part of its Series C round of funding. They join existing investors Health Enterprise Partners, Lightspeed Venture Partners and Goldman, Sachs & Co. Evariant announced in December it raised a $42.3 million Series C round of funding, bringing its total funding amount to $66 million at the time.
10 May 2016•3 mins read
